28
Participants
Start Date
September 21, 2006
Primary Completion Date
June 19, 2009
Study Completion Date
June 19, 2009
Pazopanib (GW786034)
Pazopanib (GW786034)
GSK Investigational Site, Indianapolis
GSK Investigational Site, Detroit
Lead Sponsor
GlaxoSmithKline
INDUSTRY